Medical 3D Printing

Medical 3D Printing

Learn about the invention and innovation in Medical 3D Printing of organs and tissues in this LexisNexis® Cipher report.

3D printing as a technique has been ground-breaking in the food industry, fashion industry, construction, education sector and biotechnology but how close is it to saving people’s lives? 3D printed organs and tissues has been a hot topic for years, but they are still not readily available to the public.

Our article, 3D Printing Organs and Tissues, looks at the investment and innovators driving this technology. Through a patent lens, we uncovered the following:

  • Medical 3D Printing may be the answer to increasing organ shortages and will satisfy the demand for organ transplants.
  • Despite continued investment into medical 3D printing technology, regulatory and safety related challenges persist causing a plateauing pace of invention.
  • Revotek remains the global industry leader in 3D bioprinting space with 80% of their inventions protected in China.

Use cases enabled by patent analytics

Become more effective at managing your patent portfolio, identify worldwide relevant patents and technology trends, assess the competitive landscape, and find partners and licensing opportunities.

R&D and innovation

Improve innovation with a clearly defined IP strategy that is connected to the business goals and alerts for new entrants and potential partners.

Competitive
intelligence & benchmarking

Base decision making on true patent portfolio strength and quality indicators while relying on industry-proven KPIs to track your competitors’ progress.

Portfolio optimization

Answer key questions to define international patent filing strategy, increase portfolio efficiency, and identify competitive strengths and weaknesses.

Disruptive technology scouting

Identify disruptive innovations and promising startups to help you gain a competitive edge.

Risk assessment

Stay one step ahead of your competition, disruptive technologies, important patent activity in China, and/or NPE threats. Efficiently assess the value or risk of acquisition targets.

Licensing & monetization

With analytics on all patent portfolios in all technologies, you can evaluate your most valuable patents for licensing and even identify potential licensees.

Was this post helpful?